In 1931, Dr. Paul Niehans injected a preparation of live cells from a parathyroid gland into a dying patient. The patient subsequently recovered and Dr. Niehans had an eureka moment that injections of living cells can have tremendous therapeutic value.

Today, there are 13 FDA-approved cellular therapies and over 10,000 clinical trials open for cell therapies. In comparison, there are approximately 3,000 trials open for antibodies. This small number of currently approved cellular therapy products verses the large number of trials raises the odds that a large gap in manufacturing capacity is imminent.

To read more go to http://www.pharmpro.com/blog/2017/03/cell-therapy-facility-design